The Trump administration has yet to appeal a federal court ruling that halted key elements of its childhood vaccine overhaul.
The hesitation leaves the White House caught between its Make America Healthy Again (MAHA) base and broader political calculations ahead of November's midterm elections.
Emerging Pharma Leaders nominations are now open!
Do you know someone who can make tough decisions that continue to face manufacturers? Are they destined to change the future of pharma?
Nominate a colleague with impressive leadership and career intentions – even yourself! – for the Pharmaceutical Executive 2026 Emerging Pharma Leaders Awards.
What did the court rule?
On March 16, U.S. District Judge Brian Murphy ruled that the CDC acted unlawfully when it sharply cut the number of broadly recommended childhood vaccinations in January. The judge also found that Health Secretary Robert F. Kennedy Jr.'s removal and replacement of all members of the CDC's vaccine advisory committee with ideologically aligned appointees was unlawful.
In the IDSA’s statement, attorney for the plaintiffs Richard Hughes IV of Epstein Becker Green said, “This ruling is a momentous step toward restoring science-based vaccine policymaking. The judge recognized that the actions of Secretary Kennedy and the Advisory Committee on Immunization Practices are not grounded in science and that they are destructive. We are thrilled that the court has discarded the baseless vaccine schedule changes made by Secretary Kennedy and is blocking the Advisory Committee on Immunization Practices from doing further damage to vaccine policy."2
Why hasn't the administration appealed?
Two weeks after the ruling, the administration has taken no steps to challenge it, a notably slower response than in other cases where the Trump administration has moved aggressively to contest unfavorable court decisions.
In one recent instance, the Justice Department appealed a ruling blocking construction of a White House ballroom within hours of the decision being issued.
Four senior administration officials told Reuters the path forward remains undecided, with options under consideration including, appealing the ruling on the committee removals, accepting the ruling and reconstituting the committee in line with the judge's requirements, or some combination of both.1